morning -
I believe in the partnership with ADO and Ellume. I believe Ellume's product is likely the current leader in it's niche market and ADO will benefit from this in cash flow but also in Proof of Concept.
the only other product on the market that is anywhere close to Ellume is the SpiroNose which was rolled out in the Netherlands. However what it fails to compete within is the consumer market.
No one is going to afford having some Breathalyser(which is essentially what it is) in their home nor would they want it. Furthermore this product only excels in testing for a "negative result".
if Ellume's work is rolled out and tested successfully in the US and we see not only a renewed negotiation with supply of AnteoBind then I don't see how this product and it's company doesn't reach new heights by the end of the year
Rapid Testing Competition
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $50.57M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $38.09K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1505316 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 676543 | 1 |
View Market Depth
| Last trade - 15.57pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 764931 | ||
| Last updated 15.55pm 03/05/2024 ? | |||||
| ADO (ASX) Chart |